Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL305185 | 0.74 | MAPT (0.54) | MAPTALDH1A1KDM4EGAAGLA | |
| SCHEMBL432006 | 0.74 | MAPT (0.54) | MAPTALDH1A1KDM4EGAAGLA | |
| SCHEMBL9348170 | 0.74 | MAPT (0.54) | MAPTALDH1A1KDM4EGAAGLA | |
| SCHEMBL20036958 | 0.74 | MAPT (0.54) | MAPTALDH1A1KDM4EGAAGLA | |
| SCHEMBL9346454 | 0.73 | MAPT (0.38) | MAPTALDH1A1KDM4EGAAGLA | |
| SCHEMBL4701006 | 0.73 | MAPT (0.38) | MAPTALDH1A1KDM4EGAAGLA | |
| Bromide SCHEMBL3997504 | 0.72 | MAPT (0.52) | MAPTALDH1A1KDM4EGAAGLA | |
| SCHEMBL21247206 | 0.72 | — | — | |
| SCHEMBL11298803 | 0.72 | MAPT (0.52) | MAPTALDH1A1KDM4EGAAGLA | |
| SCHEMBL8154627 | 0.72 | MAPT (1.00) | MAPTALDH1A1KDM4EGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230147021-A1 | POLYSULFIDE STABILIZATION | UNIVERSITY PUBLIC CORPORATION OSAKA (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20190270700-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | UNIV FLORIDA (US) | 2019-09-05 | — | — | US | disclosed |
| WO-2018053322-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2018-03-22 | — | — | WO | disclosed |
| CN-105254483-B | A kind of method for preparing the Dicarbonyl derivatives of 2 methyl 1,3 | 苏州大学 | 2017-11-03 | — | — | CN | disclosed |
| US-8748432-B2 | Microbiocidal pyrazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2014-06-10 | — | — | US | disclosed |
| US-8748432-B2 | Microbiocidal pyrazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2014-06-10 | — | — | US | disclosed |
| US-8188203-B2 | Intraocular lens formed from a polymer of an unsaturated aryl monoazo dye containing a 2-pyrazolin-5-one, dimedone (5,5-dimethyl-1,3-cyclohexanedione), acetoacetamide, malonamide, barbituric acid or 1,3-propanedione residue; yellow light absorbers; block ultraviolet and/or violet-blue light transmission | Abbott Medical Optics Inc. (US) | 2012-05-29 | — | — | US | disclosed |
| US-8188203-B2 | Intraocular lens formed from a polymer of an unsaturated aryl monoazo dye containing a 2-pyrazolin-5-one, dimedone (5,5-dimethyl-1,3-cyclohexanedione), acetoacetamide, malonamide, barbituric acid or 1,3-propanedione residue; yellow light absorbers; block ultraviolet and/or violet-blue light transmission | Abbott Medical Optics Inc. (US) | 2012-05-29 | — | — | US | disclosed |
| EP-2261696-B1 | Copolymerizable azo compounds and articles containing them | ABBOTT MEDICAL OPTICS INC (US) | 2012-03-14 | — | — | EP | disclosed |
| EP-2261696-A1 | Copolymerizable azo compounds and articles containing them | Abbott Medical Optics Inc. (US) | 2010-12-15 | — | — | EP | disclosed |
| US-20040160557-A1 | Article with optically modified cholesteric liquid crystal layer | VAN DE WITTE PETER (NL) | 2004-08-19 | — | — | US | disclosed |
| US-6723479-B2 | MODIFYING CHOLESTERIC REFLECTION BAND BY EXPOSURE TO ULTRAVIOLET RADIATION; LIQUID CRYSTALS | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2004-04-20 | — | — | US | disclosed |
| EP-1278646-A1 | METHOD FOR PROVIDING A SURFACE OF AN ARTICLE WITH A DECORATION OR TEXT | Koninklijke Philips Electronics N.V. (NL) | 2003-01-29 | — | — | EP | disclosed |
| EP-0932611-B1 | METAL COMPLEXES WITH AN ADAMANTANE-LIKE STRUCTURE | BASF AG (DE) | 2001-12-12 | — | — | EP | disclosed |
| US-20010046015-A1 | Method for providing a surface of an article with a decoration or text | KONINKLIJKE PHILIPS ELECTRONICS N.V. | 2001-11-29 | — | — | US | disclosed |
| WO-2001085472-A1 | METHOD FOR PROVIDING A SURFACE OF AN ARTICLE WITH A DECORATION OR TEXT | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2001-11-15 | — | — | WO | disclosed |
| US-6077965-A | Metal complexes with an adamantane-like structure | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-20 | — | — | US | disclosed |
| EP-0932611-A1 | METAL COMPLEXES WITH AN ADAMANTANE-LIKE STRUCTURE | BASF AKTIENGESELLSCHAFT (DE) | 1999-08-04 | — | — | EP | disclosed |
| WO-1998016534-A1 | METAL COMPLEXES WITH AN ADAMANTANE-LIKE STRUCTURE | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-23 | — | — | WO | disclosed |
| US-4987056-A | IMPROVED SENSITIVITY TO VISIBLE LIGHT | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1991-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230147021-A1 | POLYSULFIDE STABILIZATION | YWHAZ, YWHAH, PTPN21 | MAPT 4394/4885ALDH1A1 2635/4885KDM4E 607/4885 |
| US-20190270700-A1 | METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS | SQLE, GGPS1, LSS | MAPT 4558/4885ALDH1A1 1353/4885KDM4E 1158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.